MTX Swings to $55.6M Loss on Soaring Litigation Reserves

Ticker: MTX · Form: 10-Q · Filed: Oct 24, 2025 · CIK: 891014

Minerals Technologies Inc 10-Q Filing Summary
FieldDetail
CompanyMinerals Technologies Inc (MTX)
Form Type10-Q
Filed DateOct 24, 2025
Risk Levelhigh
Pages16
Reading Time19 min
Key Dollar Amounts$0.10
Sentimentbearish

Sentiment: bearish

Topics: Specialty Minerals, Litigation Risk, Net Loss, Revenue Decline, Cost Savings Program, Industrial Materials, Shareholder Value

Related Tickers: MTX

TL;DR

**MTX is bleeding cash due to a massive litigation hit, making it a risky bet despite a slight quarterly sales bump.**

AI Summary

MINERALS TECHNOLOGIES INC. (MTX) reported a significant net loss of $55.6 million for the nine months ended September 28, 2025, a sharp decline from a net income of $113.1 million in the prior-year period. This substantial loss was primarily driven by a $215.0 million provision for litigation reserve and credit losses, a dramatic increase from $30.0 million in the same period of 2024. Net sales for the nine-month period decreased by 2.96% to $1,553.1 million from $1,600.4 million, with both Consumer & Specialties and Engineered Solutions segments experiencing declines. The Consumer & Specialties segment saw sales drop to $823.4 million from $861.5 million, while Engineered Solutions decreased to $729.7 million from $738.9 million. Despite the nine-month loss, the company posted a net income of $43.0 million for the three months ended September 28, 2025, a slight decrease from $46.7 million in the comparable 2024 quarter, on net sales of $532.4 million, up from $524.7 million. Basic earnings per share for the nine-month period plummeted to a loss of $1.76 from earnings of $3.51, while the three-month EPS was $1.37, down from $1.45. The company also initiated a cost savings program in Q1 2025, incurring $5.5 million in severance costs, and recorded a $5.8 million charge for facility consolidation in Q2 2025.

Why It Matters

This filing reveals a critical shift in MTX's financial health, with a substantial nine-month net loss primarily due to a massive $215.0 million litigation reserve. This could significantly impact investor confidence, as such a large provision signals potential future liabilities that could further erode profitability and shareholder value. For employees, the Q1 2025 workforce reductions, costing $5.5 million in severance, indicate ongoing cost-cutting measures that could lead to further job insecurity. Customers might see impacts on product development or service levels if financial pressures persist. In a competitive market, this financial strain could weaken MTX's ability to invest in innovation or maintain market share against rivals.

Risk Assessment

Risk Level: high — The risk level is high due to the $215.0 million provision for litigation reserve and credit losses for the nine months ended September 28, 2025, which is a 616.67% increase from $30.0 million in the prior year. This significant charge directly led to a net loss of $55.6 million for the nine-month period, compared to a net income of $113.1 million previously, indicating substantial financial uncertainty and potential future liabilities.

Analyst Insight

Investors should exercise extreme caution and consider reducing exposure to MTX given the substantial litigation reserve and net loss. Await further clarity on the nature and potential resolution of the litigation, as this could continue to weigh heavily on future earnings and stock performance.

Financial Highlights

revenue
$1,553.1M
operating Margin
-0.94%
net Income
$(55.6)M
eps
$(1.76)
gross Margin
25.34%
revenue Growth
-2.96%

Revenue Breakdown

SegmentRevenueGrowth
Consumer & Specialties$823.4M-4.43%
Engineered Solutions$729.7M-1.25%

Key Numbers

  • $(55.6)M — Net Income (Loss) (Swung from $113.1M income to $55.6M loss for nine months ended Sep 28, 2025, primarily due to litigation.)
  • $215.0M — Litigation Reserve (Increased from $30.0M in prior year, driving the net loss.)
  • $1,553.1M — Net Sales (Decreased by 2.96% for the nine months ended Sep 28, 2025, compared to $1,600.4M in 2024.)
  • $(1.76) — Diluted EPS (Fell from $3.49 in prior year to a loss of $1.76 for nine months ended Sep 28, 2025.)
  • $43.0M — Q3 Net Income (Slight decrease from $46.7M in Q3 2024, showing some quarterly resilience despite nine-month loss.)
  • $532.4M — Q3 Net Sales (Increased from $524.7M in Q3 2024, indicating a modest quarterly revenue growth.)
  • $11.3M — Restructuring & Other Items (New charge for nine months ended Sep 28, 2025, including workforce reductions and facility consolidation.)
  • $129.4M — Net Cash from Operations (Decreased from $166.0M in prior year, reflecting operational challenges.)

Key Players & Entities

  • MINERALS TECHNOLOGIES INC. (company) — registrant
  • SEC (regulator) — filing oversight
  • $55.6 million (dollar_amount) — net loss attributable to Minerals Technologies Inc. for nine months ended Sep 28, 2025
  • $113.1 million (dollar_amount) — net income attributable to Minerals Technologies Inc. for nine months ended Sep 29, 2024
  • $215.0 million (dollar_amount) — provision for litigation reserve and credit losses for nine months ended Sep 28, 2025
  • $30.0 million (dollar_amount) — provision for litigation reserve and credit losses for nine months ended Sep 29, 2024
  • $1,553.1 million (dollar_amount) — net sales for nine months ended Sep 28, 2025
  • $1,600.4 million (dollar_amount) — net sales for nine months ended Sep 29, 2024
  • $5.5 million (dollar_amount) — charge for severance and related costs in Q1 2025
  • $5.8 million (dollar_amount) — charge for asset write-down and other costs in Q2 2025

FAQ

Why did Minerals Technologies Inc. report a net loss for the nine months ended September 28, 2025?

Minerals Technologies Inc. reported a net loss of $55.6 million for the nine months ended September 28, 2025, primarily due to a significant $215.0 million provision for litigation reserve and credit losses. This compares to a net income of $113.1 million in the same period of 2024, where the litigation provision was only $30.0 million.

How did Minerals Technologies Inc.'s net sales perform in the latest nine-month period?

For the nine months ended September 28, 2025, Minerals Technologies Inc.'s net sales decreased to $1,553.1 million, down from $1,600.4 million in the prior-year period. This represents a 2.96% decline, with both the Consumer & Specialties and Engineered Solutions segments experiencing reduced sales.

What was the impact of litigation on Minerals Technologies Inc.'s financial results?

Litigation had a substantial negative impact, with a provision for litigation reserve and credit losses soaring to $215.0 million for the nine months ended September 28, 2025. This compares to $30.0 million in the prior year, directly contributing to the company's $55.6 million net loss for the period.

Did Minerals Technologies Inc. implement any cost-saving measures?

Yes, Minerals Technologies Inc. initiated a cost savings program in the first quarter of 2025, primarily through workforce reductions, resulting in a $5.5 million charge for severance and related costs. Additionally, in the second quarter of 2025, the company recorded a $5.8 million charge related to the consolidation of two facilities.

How did the earnings per share change for Minerals Technologies Inc.?

Basic earnings per share for Minerals Technologies Inc. for the nine months ended September 28, 2025, was a loss of $1.76, a significant drop from earnings of $3.51 in the comparable 2024 period. For the three months ended September 28, 2025, basic EPS was $1.37, down from $1.45.

What are the two reportable segments for Minerals Technologies Inc.?

Minerals Technologies Inc. has two reportable segments: Consumer & Specialties and Engineered Solutions. The Consumer & Specialties segment includes Household & Personal Care and Specialty Additives, while the Engineered Solutions segment comprises High-Temperature Technologies and Environmental & Infrastructure.

What was the cash flow from operating activities for Minerals Technologies Inc.?

Net cash provided by operating activities for Minerals Technologies Inc. for the nine months ended September 28, 2025, was $129.4 million. This represents a decrease from $166.0 million in the same period of 2024, reflecting the impact of the net loss and changes in operating assets and liabilities.

How much did Minerals Technologies Inc. spend on share repurchases?

Minerals Technologies Inc. spent $47.5 million on the purchase of common stock for treasury during the nine months ended September 28, 2025. This is a decrease from $57.4 million spent on share repurchases in the prior-year period.

What is the current outstanding common stock for Minerals Technologies Inc.?

As of October 14, 2025, there were 31,134,308 shares of common stock, par value of $0.10 per share, of Minerals Technologies Inc. outstanding.

Are there any new accounting standards that will impact Minerals Technologies Inc.?

Yes, the FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures," effective for periods beginning after December 15, 2024, which will result in disaggregation of the company's tax footnote. Also, ASU 2024-03, "Disaggregation of Income Statement Expenses," effective for annual periods beginning after December 15, 2026, will lead to disaggregation of income statement expenses.

Risk Factors

  • Significant Litigation Reserve Impact [high — legal]: The company recorded a $215.0 million provision for litigation reserve and credit losses for the nine months ended September 28, 2025, a substantial increase from $30.0 million in the prior-year period. This provision significantly contributed to the net loss of $55.6 million for the period.
  • Restructuring and Other Charges [medium — operational]: The company incurred $11.3 million in restructuring and other items for the nine months ended September 28, 2025, including $5.5 million in severance costs for a cost savings program initiated in Q1 2025 and a $5.8 million charge for facility consolidation in Q2 2025.
  • Declining Net Sales [medium — market]: Net sales for the nine-month period decreased by 2.96% to $1,553.1 million from $1,600.4 million in the prior year. Both the Consumer & Specialties and Engineered Solutions segments experienced sales declines.
  • Reduced Cash Flow from Operations [medium — financial]: Net cash from operations decreased to $129.4 million for the nine months ended September 28, 2025, from $166.0 million in the prior-year period, indicating potential operational or working capital challenges.

Industry Context

Minerals Technologies Inc. operates in the specialty minerals and materials sector, serving diverse end markets including consumer goods, construction, and industrial applications. The industry is characterized by cyclical demand tied to global economic activity and commodity prices. Companies in this space often face challenges related to raw material costs, environmental regulations, and the need for continuous innovation to develop specialized products.

Regulatory Implications

The company is subject to various environmental, health, and safety regulations, particularly concerning mining and manufacturing operations. Compliance with these regulations requires ongoing investment and can lead to operational disruptions or fines if not met. Changes in environmental policies or stricter enforcement could pose future risks.

What Investors Should Do

  1. Monitor litigation developments
  2. Assess the effectiveness of cost savings
  3. Analyze segment performance trends

Key Dates

  • 2025-09-28: Nine months ended September 28, 2025 — Reported a net loss of $55.6 million, significantly impacted by a $215.0 million litigation reserve, and a 2.96% decrease in net sales to $1,553.1 million.
  • 2025-09-28: Three months ended September 28, 2025 — Reported a net income of $43.0 million on net sales of $532.4 million, showing quarterly resilience despite the year-to-date loss.
  • 2025-01-01: Q1 2025 — Initiated a cost savings program, incurring $5.5 million in severance costs.
  • 2025-04-01: Q2 2025 — Recorded a $5.8 million charge for facility consolidation as part of restructuring efforts.
  • 2024-09-29: Nine months ended September 29, 2024 — Reported a net income of $113.1 million and net sales of $1,600.4 million, a strong prior-year comparison.

Glossary

Provision for litigation reserve and credit losses
An amount set aside by a company to cover potential future losses arising from legal disputes or uncollectible debts. (A significant increase in this provision ($215.0M vs $30.0M) was the primary driver of the company's net loss for the nine-month period.)
Production margin
The difference between net sales and cost of goods sold, indicating the profitability of core production activities before other operating expenses. (Decreased to $393.5 million from $415.0 million for the nine-month period, reflecting lower sales and higher cost of goods sold.)
Restructuring and other items
Costs associated with significant organizational changes, such as workforce reductions, facility closures, or business realignments. (The company incurred $11.3 million in such charges in the nine-month period of 2025, impacting profitability.)
Equity in earnings of affiliates
The portion of the profits or losses of associated companies (where the company has significant influence but not control) that is recognized in the parent company's income statement. (This contributed positively to income before tax, though it decreased slightly year-over-year.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, Minerals Technologies Inc. has experienced a significant downturn. Net income has swung from a profit of $113.1 million to a loss of $55.6 million, primarily due to a substantial increase in the litigation reserve. Net sales have also declined by 2.96% to $1,553.1 million, with both key segments showing reduced revenue. Operating margins have compressed, and net cash from operations has decreased, indicating a challenging operational and financial environment compared to the previous year.

Filing Stats: 4,815 words · 19 min read · ~16 pages · Grade level 7.1 · Accepted 2025-10-24 16:05:58

Key Financial Figures

  • $0.10 — nge on which registered Common Stock, $0.10 par value MTX New York Stock Exchange

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements: Condensed Consolidated Statements of Income (Loss) for the three-month and nine-month periods ended September 28, 2025 and September 29, 2024 (Unaudited) 3 Condensed Consolidated Statements of Comprehensive Income (Loss) for the three-month and nine-month periods ended September 28, 2025 and September 29, 2024 (Unaudited) 4 Condensed Consolidated Balance Sheets as of September 28, 2025 (Unaudited) and December 31, 2024 5 Condensed Consolidated Statements of Cash Flows for the nine-month periods ended September 28, 2025 and September 29, 2024 (Unaudited) 6 Condensed Consolidated Statements of Changes in Shareholders' Equity for the three-month periods ended September 28, 2025 , June 29, 2025 and March 30, 2025 and September 29, 2024, June 30, 2024 and March 31, 2024 (Unaudited) 7 Notes to Condensed Consolidated Financial Statements (Unaudited) 9 Report of Independent Registered Public Accounting Firm 22 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 33 Item 4.

Controls and Procedures

Controls and Procedures 34

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 34 Item 1A.

Risk Factors

Risk Factors 34 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34 Item 3. Default Upon Senior Securities 35 Item 4. Mine Safety Disclosures 35 Item 5. Other Information 35 Item 6. Exhibits 35 Signature 36 2 PART 1. FINANCIAL INFORMATION

Financial Statements

ITEM 1. Financial Statements MINERALS TECHNOLOGIES INC. AND SUBSIDIARY COMPANIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) Three Months Ended Nine Months Ended Sep. 28, Sep. 29, Sep. 28, Sep. 29, (in millions of dollars, except per share data) 2025 2024 2025 2024 Net sales $ 532.4 $ 524.7 $ 1,553.1 $ 1,600.4 Cost of goods sold 395.4 389.5 1,159.6 1,185.4 Production margin 137.0 135.2 393.5 415.0 Marketing and administrative expenses 53.0 50.1 155.8 156.4 Research and development expenses 5.6 5.9 17.1 17.3 Provision for litigation reserve and credit losses - - 215.0 30.0 Restructuring and other items - - 11.3 - Gain on sale of assets, net - - ( 5.6 ) - Litigation expenses 7.5 2.6 14.5 8.9 Income (loss) from operations 70.9 76.6 ( 14.6 ) 202.4 Interest expense, net ( 13.8 ) ( 14.0 ) ( 41.6 ) ( 43.8 ) Other non-operating deductions, net ( 0.5 ) ( 3.1 ) ( 4.4 ) ( 4.4 ) Total non-operating deductions, net ( 14.3 ) ( 17.1 ) ( 46.0 ) ( 48.2 ) Income (loss) before tax and equity in earnings 56.6 59.5 ( 60.6 ) 154.2 Provision (benefit) for taxes on income 13.5 13.7 ( 4.7 ) 43.2 Equity in earnings of affiliates, net of tax 1.1 1.9 3.4 5.2 Net income (loss) 44.2 47.7 ( 52.5 ) 116.2 Less: Net income attributable to non-controlling interests 1.2 1.0 3.1 3.1 Net income (loss) attributable to Minerals Technologies Inc. $ 43.0 $ 46.7 $ ( 55.6 ) $ 113.1 Earnings (loss) per share: Basic: Net income (loss) attributable to Minerals Technologies Inc. $ 1.37 $ 1.45 $ ( 1.76 ) $ 3.51 Diluted: Net income (loss) attributable to Minerals Technologies Inc. $ 1.37 $ 1.45 $ ( 1.76 ) $ 3.49 Cash dividends declared per common share $ 0.11 $ 0.10 $ 0.33 $ 0.30 Shares used in computation of earnings (loss) per share: Basic 31.3 32.1 31.6 32.2 Diluted 31.3 32.3 31.6 32.4 See accompanying Notes to Condensed Consolidated Financial Statements. 3 MINERALS TECHNOLOGIES INC. AND SUBSIDIARY COMPANIES CONDENSED CONSOLIDATED STATEM

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.